Publications of U. Reichl

Schwarzer, J.; Wolff, M. W.; Rapp, E.; Schmidt, J. K.; Opitz, L.; Reichl, U.: Glycosylation of Influenza A Virus Hemagglutinin. CCE IX (Cell Culture Engineering IX) 2004, Riviera Maya , Cancun, QR, Mexico (2004)

Genzel, Y.; Alt, R.; Reichl, U.: Glutamine-free media for vaccine production processes. 18th ESACT Meeting, Granada, Spain (2003)

Genzel, Y.; Best, C.; Behrendt, I.; König, S.; Sann, H.; Bock, A.; Reichl, U.: Optimization & Scale-up of Bioprocesses: Influenza Vaccine Production in Microcarrier Systems. Bioengineering Course (BEC), Supetar, Croatia (2003)

Hundt, B.; Reichl, U.: Comparing wave and stirred-tank bioreactor performance for vaccine production with feline lung fibroblasts. 11th Congress on biotechnology, Basel, Switzerland (2003)

Hundt, B.; Reichl, U.; Schänzler, A.: Serum-free cultivation of CEF for vaccine production in microcarrier-systems. 18th ESACT Meeting, Granada, Spain (2003)

Möhler, L.; Bock, A.; Sann, H.; Reichl, U.: Mathematical Modeling of MDCK Cell Growth by the Use of On-line Data. DECHEMA Jahrestagung der Biotechnologen, Munich, Germany (2003)

Sann, H.; Bock, A.; Reichl, U.: Investigation of a new, sterile, deadvolume free sampling-system for universal applications, automated and suitable for online-analyzing. DECHEMA Jahrestagung der Biotechnologen, Munich, Germany (2003)

Schmidt, J. K.; König, B.; Reichl, U.: Cooperation and competition: studies on heterogeneous microbial cultures. Jahrestagung der Vereinigung für allgemeine und angewandte Mikrobiologie (VAAM), Berlin, Germany (2003)

Sidorenko, Y.; Sann, H.; Reichl, U.: Structured model of Influenza virus replication in MDCK cells. 11th Congress on biotechnology, Basel, Switzerland (2003)

Genzel, Y.; Reichl, U.: Analysis of cell growth, virus replication and medium composition in equine influenza vaccine production. IUMS 2002, Paris, France (2002)

Genzel, Y.; Reichl, U.: Analysis of cell growth, virus replication and medium composition in equine influenza vaccine production. GVC/Dechema Jahrestagungen 2002, Wiesbaden, Germany (2002)

Genzel, Y.; Voges, L.; Reichl, U.: Development of bioprocess concepts on vaccine production: influenza virus as an example. 17th ESACT Meeting, Tyloesand, Sweden (2001)

Pelz, L.; Rüdiger, D.; Alnaji, F. G.; Genzel, Y.; Brooke, C. B.; Kupke, S. Y.; Reichl, U.: Semi-continuous propagation of influenza A virus and its defective interfering particles: analyzing the dynamic competition to select candidates for antiviral therapy. bioRxiv (2021)

Prerna , A.; Bdeir, N.; Gärtner, S.; Reiter, S.; Pelz, L.; Felgenhauer, U.; Reichl, U.; Ludwig, S.; Weber, F.; Hoffmann, M. et al.; Winkler, M.; Pöhlmann , S.: Interferon induction and not replication interference mainly determines anti-influenza virus activity of defective interfering particles. bioRxiv (2021)

Van Den Bossche, T.; Kunath, B. J.; Schallert, K.; Schäpe, S. S.; Abraham, P. E.; Armengaud, J.; Arntzen, M. Ø.; Bassignani, A.; Benndorf, D.; Fuchs, S. et al.; Giannone, R. J.; Griffin, T. J.; Hagen, L. H.; Halder, R.; Henry, C.; Hettich, R. L.; Heyer, R.; Jagtap, P.; Jehmlich, N.; Jensen, M.; Juste, C.; Kleiner, M.; Langella, O.; Lehmann, T.; Leith, E.; May, P.; Mesuere, B.; Miotello, G.; Peters, S. L.; Pible, O.; Reichl, U.; Renard, B. Y.; Schiebenhoefer, H.; Scryba, A.; Tanca, A.; Trappe, K.; Trezzi, J.-P.; Uzzau, S.; Verschaffelt, P.; von Bergen, M.; Wilmes, P.; Wolf, M.; Martens, L.; Muth, T.: Critical Assessment of Metaproteome Investigation (CAMPI): A Multi-Lab Comparison of Established Workflows. bioRxiv (2021)

Grabherr, R.; Reichl, U. (Eds.): Vaccine Biotechnology (Special issue). Biotechnology Journal 10, (5) (2015)

Rapp, E.; Reichl, U.: Preface to Advances in Glycobiotechnology. Advances in Glycobiotechnology, pp. i - vi (2021)

Grabherr, R.; Reichl, U.: Can modern vaccine technology pursue the success of traditional vaccine manufacturing? Biotechnology Journal 10 (5), pp. 657 - 658 (2015)

Kupke, S. Y.; Frensing, T.; Zmora, P.; Reichl, U.: Protective Interfering Nucleic Acid Molecule And Virus - Like Particle, Virsl Vector, or Virus Particle Containing the same as well as Pharmaceutical Composition Containing the Protective Interfering Nucleic Acid and its use. US 2020/0392504A1 (2020)

Tapia, F.; Genzel, Y.; Reichl, U.: Plug Flow Tubular Bioreactor , System Containing the same and Method for Production of Virus. US 20190119616A1 (2019)